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Objective: In a rat monoiodoacetic acid (MIA)-induced arthritis model, the amount of MIA commonly
used was too high, resulting in rapid bone destruction. We examined the effect of MIA concentrations on
articular cartilage and infrapatellar fat pad (IFP). We also established an original system for “macroscopic
cartilage and bone score” and “IFP inﬂammation score” speciﬁc to the rat MIA-induced arthritis model.
Design: Male Wistar rats received a single intra-articular injection of MIA in the knee. The amount of MIA
was 0.1, 0.2, 0.5, and 1 mg respectively. Articular cartilage was evaluated at 2e12 weeks. IFP was also
observed at 3e14 days.
Results: Macroscopically, low MIA doses induced punctate depressions on the cartilage surface, and
cartilage erosion proceeded slowly over 12 weeks, while higher MIA doses already induced cartilage
erosion at 2 weeks, followed by bone destruction. MIA macroscopic cartilage and bone score, OARSI
histological score, and Mankin score increased in a dose- and time-dependent manner. The IFP
inﬂammation score peaked at 5 days in low dose groups, then decreased, while in high dose groups, the
IFP score continued to increase over 14 days due to IFP ﬁbrosis.
Conclusions: Punctate depressions, cartilage erosion, and bone destruction were observed in the MIA-
induced arthritis model. The macroscopic cartilage and bone scoring enabled the quantiﬁcation of
cartilage degeneration and demonstrated that MIA-induced arthritis progressed in a dose- and time-
dependent manner. IFP inﬂammation scores revealed that 0.2 mg MIA induced reversible synovitis,
while 1 mg MIA induced ﬁbrosis of the IFP body.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Osteoarthritis (OA) is one of the most prevalent joint diseases,
especially in women1. To explore the pathological mechanismsI. Sekiya, Center for Stem Cell
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d/4.0/).behind OA and develop new treatments, it is essential to establish
optimal OA animal models. Inﬂammation as well as mechanical
stress triggers OA and affects its progression2e4. Monoiodoacetic
acid (MIA) is commonly used to induce arthritis in rats, primarily in
studies of arthritis-related pain5,6. However, in most cases the large
amount of MIA for these studies resulted in bone destruction
beyond cartilage inﬂammation within a short period of time5,7,8.
We made a hypothesis that low dose of MIA induced mild inﬂam-
matory features of the cartilage. The ﬁrst aim of this study was to
describe cartilage characteristics during the progression of arthritis
induced by various amounts of MIA in rats.
To properly evaluate arthritis progression, a quantitative eval-
uation tool to describe whole features is required to comparesearch Society International. This is an open access article under the CC BY-NC-ND
Table I
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studies. For this reason, there are several scoring systems to eval-
uate cartilage degenerationmacroscopically in each study that used
arthritis models7,9e12. However, cartilage inﬂammation can vary
with each model, especially in its early phase, and current scoring
systemsmay not be precise enough to fully categorize each phase of
disease progression. The second aim of this study was to establish
an original scoring system to quantify arthritis of the knee joint
speciﬁcally for the rat MIA-induced arthritis model.
Synovitis is an important pathological condition in arthritis and
OA, and the infrapatellar fat pad (IFP) is a useful tissue to evaluate
synovitis. There are some scoring systems to evaluate synovitis13,14,
however, these systems only evaluate the cell lining layers, ignoring
the body of the IFP, though ﬁbrosis of the IFP is an important
pathological condition related to synovitis15. The third aim of this
work was to establish an IFP inﬂammation score capable of eval-
uating both the surface and body of the IFP and to quantify synovitis
in the rat MIA-induced arthritis model.
Materials & methods
Animals
This study was approved by the Animal Committee of Tokyo
Medical and Dental University. All animal care and experiments
were conducted in accordance with the institutional guidelines of
our Animal Committee. One hundred and twenty male Wistar rats
(Charles River, Japan) at 8 weeks of age, 270e285 g in weight, were
used for the study.
Preparation of MIA arthritis model for cartilage evaluation
Monosodium iodoacetate (SigmaeAldrich, St. Louis, MO) was
dissolved in saline and used as MIA. Under anesthesia by isoﬂurane
inhalation and intraperitoneal injection of tribromoethanol, the
right knee joint had a single intra-articular injection of MIA in 50 ml
of sterile saline. The dose of MIA was 0.1, 0.2, 0.5, or 1.0 mg/50 ml
and 20 rats were used for each dose. The left knee joint received an
injection of saline. The left knee of rats which had a 0.1 mg injection
in the right kneewas used as control. The knee ﬁxed at 90 andMIA
or phosphate buffer saline (PBS) was injected through patellar
tendon. After the injection, the animals were returned to their
cages and kept under a 12/12 h light/dark cycle with food and
water.
Macroscopic observation
The knee joints were harvested at 2, 4, 6, 8, and 12 weeks after
injection (Fig. 1). The tibial plateauwas carefully separated from the
femoral condyle. Macroscopic pictures of the femoral and tibial
condyles were taken using a ZIESS Stemi 2000C microscope (Zeiss,
Oberkochen, Germany) on a dedicated medical photographyFig. 1. Study schema. Rats had a single monoiodoacetic acid (MIA) injection in the
right knee and phosphate buffer saline (PBS) in the left knee. The knees were evaluated
at 2, 4, 6, 8 and 12 weeks after injection. For the control, the left knee of rats which had
a 0.1 mg injection in the right knee, was used.platform. Quantiﬁcation of the size of the cartilage legion was
performed using AxioVision Rel 4.8 software (Zeiss). The cartilage
degeneration and bone destruction of the femoral and tibial con-
dyles were evaluated using a macroscopic score on a scale of 0e5
points (Table I).
Histological examination
Proximal tibias were ﬁxed in 4% paraformaldehyde for 7 days,
decalciﬁed in 20% EDTA solution for 21 days, and then embedded in
parafﬁn wax. The specimens were sagittally sectioned at 5 mm and
stained with safranin-o and fast green. Histological sections were
visualized using an Olympus BX53 microscope (Olympus, Tokyo,
Japan). The cartilage degeneration of the medial tibial plateau was
evaluated using OARSI score16 on a scale of 0e24 points and
Mankin score on a scale of 0e14 points17.
Immunostaining
Parafﬁn-embedded sections were deparafﬁnized in xylene,
rehydrated in graded alcohol, and washed in PBS. All subsequent
incubations were performed in a humidiﬁed chamber. The section
was pretreated with proteinase K (Dako, Glostrup, Denmark) in Tris
HCl buffer for 15 min at room temperature for optimal antigen
retrieval. Then endogenous peroxidases were quenched using 0.3%
hydrogen peroxidase in methanol for 15 min. Primary antibodies
for human anti-type II collagen (Kyowa Pharma Chemical, Toyama,
Japan) were applied to sections and incubated at room temperature
for 1 h. After extensive washes with PBS, the sections were incu-
bated in the biotinylated horse anti-mouse IgG for type II collagen.
Immunostaining was detected with Vectastain ABC regent (Vector,
Burlingame, CA) followed by diaminobenzidine staining. The sec-
tions were counterstained with hematoxylin.
Evaluation of synovitis
For the evaluation of synovitis, 40 rats were divided into two
groups and 0.2 or 1.0 mg of MIA in 50 ml of sterile saline was
injected into the right knee joint. The whole knee joint was har-
vested at 0, 3, 5, 7, and 14 days after the injection and prepared for
histological evaluation as described previously (Fig. 5). The slides
were stained with hematoxylin and eosin (HE), and the synovitis
was evaluated using the IFP inﬂammation score on a scale of 0e6
points (Table II).
Statistical analysis
The scores were evaluated by three independent observers,
where two observers evaluated in a blinded manner. For histology,
one representative slice was evaluated. Interclass correlationMacroscopic cartilage and bone scoring (0e5) for rat arthritis induced by mono-
iodoacetic acid (MIA)
Points Findings
0 Intact articular surface
1 &10 punctate depressions per condyle*
2 >10 punctate depressions per condyle*
3 Erosion (&50% of joint surface)
4 Erosion (>50% of joint surface)
5 Bone destruction
Both lateral condyle and medial condyle were evaluated separately, and the higher
point value was selected for femur and tibia respectively.
* Condyle; lateral femoral condyle, medial femoral condyle, lateral tibial condyle
or medial tibial condyle.
Table II
Infrapatellar fat pad (IFP) inﬂammation scoring (0e6)
Points Histological signs
Cell inﬁltration at the surface of the IFP
0 Normal
1 Cellularity is increased, multinucleated
cells present
2 Thickened lining cells, low (<threefold thickness
of the normal synovium)
3 Thickened lining cells, high (>threefold thickness
of the normal synovium)
Points Histological signs
Fibrosis in the body of the IFP
0 No ﬁbrotic lesion
1 Fibrotic lesion in infrapatellar fat-pad present, low
2 Fibrotic lesion is increased, high
3 Infrapatellar fat-pad ﬁlled with the ﬁbrotic lesion
and fat cells absent
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observers were 0.948 (macroscopic score), 0.975 (histological
score), and 0.962 (synovitis score). The scores evaluated by single
observer were demonstrated.Fig. 2. Representative macroscopic features of the femoral and tibial condyle cartilage. (A)
shown in each image. The tibial image with median value is selected among four samples an
knee were inverted horizontally to match the images in the other groups. (B) Images with Ind
surrounded with yellow arrowheads. Areas of bone destruction are surrounded with red aThe sample size was four for each group. The analysis unit was a
group dependent of MIA dose in each period. The non-parametric
SteeleDwass test was performed using StatView 5.0 (SAS Insti-
tute, Cary, NC) for the analyses of macroscopic score, OARSI score,
Mankin score and synovitis score. P values less than 0.05 were
considered signiﬁcant.Results
Macroscopic observation of tibial cartilage
In the control group, cartilage in the left knee of rats, which had a
0.1 mg injection in the right knee, was not affected over 12 weeks
[Fig. 2(A)].Nocartilage lesionwasobserved in theﬁrst 4weeks in the
0.1 mg group. Some punctate depressions were ﬁrst observed at 6
weeks. Theseweremore apparent after India ink staining [Fig. 2(B)].
Punctate depressions enlarged but cartilage surface was still glossy
at 8 weeks. The number of punctate depressions increased at 12
weeks. In the0.2mggroup, somepunctatedepressionswerealready
observed at 4weeks. The number of punctate depressions increased
at 6 weeks. Cartilage erosionwas observed at 8 and 12weeks. In the
0.5mggroup, cartilage erosionwas alreadyobservedat 2weeks, and
occupied most of the surface at 4 weeks. Bone destruction emergedImages without India ink staining. Macroscopic cartilage score introduced in Table I is
d the femur is selected from the same knee. In the control group, the images of the left
ia ink staining. Punctate depressions are indicated with white arrowheads. Erosions are
rrowheads. A; anterior, P; posterior, M; medial, L; lateral.
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cartilage erosion occupied most of the articular surface at 2 weeks.
Bone destruction was evident at 4 weeks and thereafter. The
macroscopic features of femoral cartilage appeared to be similar to
those of tibial cartilage. In the control group which had 0.2 mg,
0.5 mg or 1 mg injection in the right knee, was not affected over 12
weeks (Images were not shown).
Quantiﬁcation of macroscopic features for tibial cartilage
To quantify the macroscopic features of cartilage from the knee,
we established a macroscopic cartilage and bone score speciﬁc for
rat arthritis induced by MIA (Table I). In the 0.1 mg group, the score
for the tibial cartilage was 0 at 2 weeks, and then gradually
increased thereafter. In the 0.2 mg group, the score was 0.3 at 2
weeks, increased gradually at 4 and 6 weeks, and reached a plateau
from 8 to 12 weeks. In the 0.5 mg group, the score was 2.8 at 2
weeks, increased rapidly at 4 weeks, gradually increased at 6 and
reached the maximum score of 5 from 8 to 12 weeks. In the 1 mg
group, the score was 3.8 at 2 weeks, and then reached to the
maximum score by 4 weeks on. The scores for femoral cartilage
showed similar trends to the scores for tibial cartilage (Fig. 3).
Histological observations of tibial cartilage
In the control group, cartilage evaluated by safranin-o staining
was not affected over 12 weeks [Fig. 4(A)]. In the 0.1 mg group,
cartilage matrix staining slightly decreased at 2 weeks, and then
continued to decrease thereafter [Fig. 4(A)], though cartilagematrix
evaluated by type II collagen immunostaining was not similarly
affected (Supplementary Fig. 1). In the 0.2 mg group, staining
decreasedmoderately at 2 weeks, andwas lost to the deep zone at 4
weeks and thereafter, though remaining cartilage matrix was still
positive for type II collagen (Supplementary Fig. 1). In the 0.5 mg
and 1 mg groups, subchondral bone was already exposed at 2
weeks and began eroding at 4 weeks and thereafter.
Quantiﬁcation of histological features of tibial cartilage
Histological features for tibial cartilage were quantiﬁed by
OARSI score [Fig. 4(B)]. In the 0.1 mg group, the score was 3.5 at 2
weeks, and then gradually increased thereafter. In the 0.2 mg
group, the score was 5.5 at 2 weeks, then rapidly increased at 4
weeks, and remained relatively unchanged thereafter. In the 0.5Fig. 3. Macroscopic cartilage score for femoral condyle and tibial pland 1.0 mg groups, the scores were 19 and 20 at 2 weeks, and then
reached to the maximum of 24 at 4 weeks. Histological features
were also quantiﬁed byMankin score, which showed similar trends
to that of OARSI score [Fig. 4(C)].
IFP inﬂammation
To evaluate synovitis, 0.2 mg or 1 mg MIA was injected and the
IFP was histologically evaluated [Fig. 5(A)]. In the 0.2 mg group, the
thickness of lining cells at the surface of the IFP increased and
ﬁbrosis was observed in the body of the IFP at 3 days [Fig. 5(B)]. The
ﬁbrosis area enlarged at 5 days, but decreased at 7 days. The
thickness of lining cells decreased at 14 days. In the 1 mg group,
synovitis similar to that in the 0.2mg groupwas observed at 3 and 5
days respectively. The thickness of lining cells further increased at 7
days, and ﬁbrosis occupied the entire body of the IFP at 14 days.
To quantify inﬂammation, an IFP inﬂammation score was
established (Table II). This IFP inﬂammation score consisted of “Cell
inﬁltration at the surface of the IFP” and “Fibrosis in the body of the
IFP”. The IFP inﬂammation scores increased at 3 and 5 days
[Fig. 5(C)]. The score then decreased in the 0.2 mg group, but
increased further in the 1 mg group at 7 and 14 days.
Discussion
In this study, 0.1 mg MIA induced punctate depressions at 6
weeks but did not induce erosion until 12 weeks. At 0.2 mg, MIA
induced punctate depressions at 4weeks and erosion at 8 weeks. At
0.5 mg and 1 mg, MIA induced bone destruction in as early as 4
weeks. MIA-induced arthritis progression was dose- and time-
dependent. These results provide valuable information for the
standardization of joint inﬂammation induced by MIA.
One of mechanisms by which MIA induces arthritis is by
decreasing proteoglycan content. We demonstrated that cartilage
matrix stained by safranin-o already decreased at 2 weeks after
even with the 0.1 mg MIA injection, though cartilage matrix
immunostained by type II collagen was not affected. Another
mechanism of MIA action is reduced chondrocyte metabolism and
induced death of chondrocytes by inhibition of the glycolytic
system7.
There have been several previous reports demonstrating the
inﬂammatory morphology of knee joints induced by MIA in Wistar
rats. Some papers observed results similar to ours. Mohan et al.
observed cartilage degeneration at 10 weeks after the injection ofateau. Values are means with 95% conﬁdence interval (n ¼ 4).
Fig. 4. Histological analyses for the tibial condyle. (A) Representative histological features of the tibial condyle. Medial tibial condyle was sectioned in the sagittal plane and stained
with safranin-o. OARSI histological score and Mankin score are shown in each image. The tibial plateau image with median value is demonstrated. A; anterior, P; posterior, O; OARSI
histological score, M; Mankin score. (B) OARSI histological score for tibial cartilage. Values are means with 95% conﬁdence interval (n ¼ 4). (C) Mankin score for tibial cartilage.
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degeneration were similar to ours and OARSI histological scores
were almost equal to ours18. Thote et al. induced cartilage degen-
eration by 0.2 mg MIA and showed exposure of subchondral bone
at 3 weeks19, which was similar to ours. Clemants et al. reported
subsynovial ﬁbrosis in infrapatellars fat pads 21 days after 1 mg
MIA injection16, again, results similar to ours.
Other previous papers showed different results from ours, in part
or as a whole. Guingamp et al. reported that the cartilage at 30 days
after injections of 0.1 mg MIA looked similar to ours, however, the
bonedestructionwas not observed even after injection of 3mgMIA8.
Ferreira-Gomes et al. showed that 0.3 mg MIA induced cartilage
degeneration at 31 days17 which was similar to ours, however, 1 mg
and2mgMIAdidnot inducebonedestructionevenat4weeks,which
was different than ours. Bove et al. reported the absence morpho-
logical changes of the knee joint induced by 1 mg MIA after 7 days5.
The variation in the results of these three papers and in ours could
likely be attributed to the different rat body weights; rats used in
these three papers were lighter, suggesting younger rats were used.
Wistar ratswere used in this study and the effects ofMIA in the knee
joint may differ between rat strains. Mapp et al. injected 1 mg MIA
into SpragueeDawley rats and observed less bone destruction
though the same amountofMIAwasused19,20. Even the 2mgor 3mg
MIA did not induce bone destruction19,21. Thakur et al. and Pomoniset al. comparedhistopathologicalﬁndings of different doses ofMIA in
SpragueeDawley rats. The doses were effective, however, the carti-
lage degeneration looked milder than that of 1 mg MIA in Wistar
rats22,23. Given the results fromourﬁndings, the differences between
strains must be noted when applying these data.
The amount of MIA administered and time after MIA injection
were important factors affecting the severity of arthritis. Though
we did not identify how long MIA remained in the knee joint,
histological features for cartilage degeneration progressed for at
least 12 weeks, even after injection of 0.1 mg MIA. This indicates
that even a low amount of MIA is sufﬁcient to produce cartilage
degeneration without bone destruction, which is similar to the
pathology of OA. Future animal models could be developed using
lower concentrations of MIA over longer periods of time that may
also beneﬁt from the scoring system. To quantitate the macroscopic
features for rat MIA arthritis models, Guingamp et al. previously
reported a simple scoring system, a scale of 0e4 of increasing
severity (0¼ normal; 4¼maximum severity)7, whichwas also used
by others12,24. This system lacks the complexity to quantitate and
describe many of the macroscopic features of cartilage degenera-
tion induced by MIA.
We included punctate depressions in our macroscopic cartilage
and bone scoring system. Punctate depressions are dotted erosive
cartilage lesions, approximately 0.1 mm in diameter, observed in
Fig. 5. Analysis for infrapatellar fat pad (IFP). (A) Study schema. (B) Representative histological images for the IFP. Whole knee joints were sectioned in the sagittal plane stained
with hematoxylin and eosin. Infrapatellar fat pad inﬂammation score (surface score þ body score) are shown in each image. (C) Infrapatellar fat pad inﬂammation score. Values are
means with 95% conﬁdence interval (n ¼ 4).
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pressions were demonstrated in rats but may be observed in other
animals as well. We observed punctate depressions in the ﬁgures of
a previous paper where MIA was injected into the knee of Wistar
rats, where the punctate depressions were termed focal erosions7.
In another paper, MIA was injected into the knee of Spra-
gueeDawley rats, and punctate depressions could be also observed
but were termed “mild damage”10. We deﬁned punctate
depressions in our paper for the ﬁrst time. We set 10 punctate
depressions per condyle as the cut off between one and two points
in the macroscopic cartilage and bone scoring system, because at
that cutoff, the number of samples with each score in the MIA 0.1
and 0.2 mg groups were nearly identical.OARSI histological scores and Mankin scores reached their
maximumvalues by 4 weeks after 0.5 or 1mgMIA injections. These
dosages of MIA are too high to evaluate cartilage, because they
resulted in not only cartilage inﬂammation, but also rapid bone
destruction. To examine the effects of drugs and surgical in-
terventions on modifying arthritis progression, MIA injections
greater than 0.5 mg would be inappropriate to evaluate by histo-
logical scoring after 4 weeks.
For histological analysis, we evaluated the medial tibial condyle
and not the lateral tibial condyle, because macroscopic cartilage
and bone scores were higher for themedial condyle than the lateral
condyle in the majority of samples. In other papers reporting knee
inﬂammation induced by MIA in Wistar rats, only the medial
M. Udo et al. / Osteoarthritis and Cartilage 24 (2016) 1284e12911290condyle was demonstrated histologically25. There are several
reports showing that load distribution is higher on the medial side
of the femorotibial joint than on the lateral side in rats20,21,26.
Synovitis is one of the typical features of arthritis including OA2
and in clinical pathology, and synovitis can adversely affect joint
function27. There were no obvious differences in inﬂammation of
the IFP between in the 0.2mgMIA group and in the 1mgMIA group
at 3 and 5 days. After 5 days, inﬂammation of the IFPwas reduced in
the 0.2mg group but progressed in the 1mg group at 7 and 14 days.
This suggests that low amounts of MIA induce reversible inﬂam-
mation of the IFP, while high amounts of MIA induce sustained
inﬂammation of the IFP.
The injection of 1 mgMIA induced ﬁbrosis of the body of the IFP.
Though an important ﬁnding, this was not reﬂected by the previous
synovitis scoring system13. To quantitate the ﬁbrosis in the body of
the IFP, we established the IFP inﬂammation score, which grades
“cell inﬁltration at the surface of the IFP” and “ﬁbrosis in the body of
the IFP”. This scoring system could enable the clariﬁcation of
temporal and sustained inﬂammation of the IFP.
We examined only two doses of MIA in contrast to the evalua-
tion of articular cartilage at four doses. According to previous
reports7,18,28,29 and ours, we regarded 0.2 mg MIA as the
representative of a low dose MIA model and 1 mg MIA as the
representative of a high dose MIA model. For this study, we did not
prepare a control for which the effect of injury caused by inserting a
needle with saline into the knee joint was tested. One ﬁnal
consideration is that here we used Wistar rats at 8 weeks of age.
The growth plate of 8 weeks old rats remained open, indicating
possibility of skeletal immaturity. However, 7e8 weeks old rats are
sexually mature30. There are many published papers in which
Wistar rats at 8 weeks old and younger were used for arthritis
induced by MIA5,18,28,29. The use of rats at 8 weeks of age is popular
for arthritis models induced by MIA.
In this study, MIA-induced degenerative changes of cartilage
and bone were time- and dose-dependent. Also, inﬂammatory
changes of the IFP were reversible in the 0.2 mg MIA group, but
irreversible in the 1.0 mg MIA group. When an MIA-induced
arthritis model is used for a speciﬁc study, MIA dose and observa-
tion period should be carefully considered to suit the intended
study duration and pathology. The proper application of MIA for
rats could provide a useful tool to help determine the safety and
efﬁcacy of future arthritis treatments.
Conclusions
Low dose MIA induced punctate depressions on the surface of
cartilage at 0.1 mg and 0.2 mg, and cartilage erosion proceeded
with time, in Wistar rats. Higher doses at 0.5 mg and 1 mg MIA
induced bone destruction at 4 weeks. We established a macro-
scopic cartilage and bone scoring system that enabled facile
quantiﬁcation of cartilage degeneration and demonstrated that
MIA-induced arthritis progression is dose- and time-dependent. An
IFP inﬂammation score revealed that 0.2 mg MIA induced revers-
ible synovitis, while 1 mgMIA induced irreversible synovitis. Taken
together these data present a compelling new use for low MIA
dosing to study arthritis in pre-clinical animal models.
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